Ex Vivo Generation and Characterization of Human Hyaline and Elastic Cartilaginous Microtissues for Tissue Engineering Applications.

dc.contributor.authorSánchez-Porras, David
dc.contributor.authorDurand-Herrera, Daniel
dc.contributor.authorPaes, Ana B
dc.contributor.authorChato-Astrain, Jesús
dc.contributor.authorVerplancke, Rik
dc.contributor.authorVanfleteren, Jan
dc.contributor.authorSánchez-López, José Darío
dc.contributor.authorGarcía-García, Óscar Darío
dc.contributor.authorCampos, Fernando
dc.contributor.authorCarriel, Víctor
dc.date.accessioned2025-01-07T17:04:58Z
dc.date.available2025-01-07T17:04:58Z
dc.date.issued2021-03-12
dc.description.abstractConsidering the high prevalence of cartilage-associated pathologies, low self-repair capacity and limitations of current repair techniques, tissue engineering (TE) strategies have emerged as a promising alternative in this field. Three-dimensional culture techniques have gained attention in recent years, showing their ability to provide the most biomimetic environment for the cells under culture conditions, enabling the cells to fabricate natural, 3D functional microtissues (MTs). In this sense, the aim of this study was to generate, characterize and compare scaffold-free human hyaline and elastic cartilage-derived MTs (HC-MTs and EC-MTs, respectively) under expansion (EM) and chondrogenic media (CM). MTs were generated by using agarose microchips and evaluated ex vivo for 28 days. The MTs generated were subjected to morphometric assessment and cell viability, metabolic activity and histological analyses. Results suggest that the use of CM improves the biomimicry of the MTs obtained in terms of morphology, viability and extracellular matrix (ECM) synthesis with respect to the use of EM. Moreover, the overall results indicate a faster and more sensitive response of the EC-derived cells to the use of CM as compared to HC chondrocytes. Finally, future preclinical in vivo studies are still needed to determine the potential clinical usefulness of these novel advanced therapy products.
dc.identifier.doi10.3390/biomedicines9030292
dc.identifier.issn2227-9059
dc.identifier.pmcPMC8001313
dc.identifier.pmid33809387
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8001313/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2227-9059/9/3/292/pdf?version=1616407968
dc.identifier.urihttps://hdl.handle.net/10668/28163
dc.issue.number3
dc.journal.titleBiomedicines
dc.journal.titleabbreviationBiomedicines
dc.language.isoen
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectextracellular matrix
dc.subjecthuman elastic chondrocytes
dc.subjecthuman hyaline chondrocytes
dc.subjectmicrotissues
dc.subjectorganoids
dc.subjecttissue engineering
dc.titleEx Vivo Generation and Characterization of Human Hyaline and Elastic Cartilaginous Microtissues for Tissue Engineering Applications.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number9

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8001313.pdf
Size:
6.13 MB
Format:
Adobe Portable Document Format